These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6753852)

  • 1. Circulating immune complexes in patients with progressive systemic sclerosis.
    Siminovitch K; Klein M; Pruzanski W; Wilkinson S; Lee P; Yoon SJ; Keystone E
    Arthritis Rheum; 1982 Oct; 25(10):1174-9. PubMed ID: 6753852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes in progressive systemic sclerosis (scleroderma).
    Seibold JR; Medsger TA; Winkelstein A; Kelly RH; Rodnan GP
    Arthritis Rheum; 1982 Oct; 25(10):1167-73. PubMed ID: 6753851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
    Fiocco GP; Davis JS; Burge JJ
    Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of circulating immune complexes in chronic lung diseases.
    Cooper KM; Moore M
    J Clin Lab Immunol; 1982 Apr; 7(3):155-61. PubMed ID: 6980284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes and autoantibodies in lung cancer.
    Guy K; Di Mario U; Irvine WJ; Hunter AM; Hadley A; Horne NW
    Br J Cancer; 1981 Mar; 43(3):276-83. PubMed ID: 7225280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating antigen-antibody complexes in onchocerciasis.
    Steward MW; Sisley B; Mackenzie CD; El Sheikh H
    Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in rheumatic fever.
    Kawakami K; Hokonohara M; Miyata K; Terawaki T
    Jpn Circ J; 1982 Nov; 46(11):1188-91. PubMed ID: 6982348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.
    Malia RG; Greaves M; Rowlands LM; Lawrence AC; Hume A; Rowell NR; Moult J; Holt CM; Lindsey N; Hughes P
    Clin Exp Immunol; 1988 Sep; 73(3):456-60. PubMed ID: 2974767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between circulating immune complexes and renal disease in New Zealand mice.
    Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
    Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in multiple sclerosis: relation with disease activity.
    Dasgupta MK; Warren KG; Johny KV; Dossetor JB
    Neurology; 1982 Sep; 32(9):1000-4. PubMed ID: 6981073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of assays for circulating immune complexes.
    Endo L; Corman LC; Panush RS
    Med Clin North Am; 1985 Jul; 69(4):623-36. PubMed ID: 3903373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
    Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.